|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000095766 |
| 005 |
20191021093000.0 |
| 008 |
190526s2012 nyu eng |
| 020 |
|
|
|a 9780702042997
|
| 040 |
|
|
|a UniSZA
|e rda
|
| 050 |
0 |
0 |
|a RS61
|b .D78 2013
|
| 060 |
0 |
0 |
|a QV11.1
|b .D78 2013
|
| 090 |
0 |
0 |
|a RS61
|b .D78 2013
|
| 245 |
0 |
0 |
|a Drug discovery and development :
|b technology in transition
|c edited Raymond Hill and Humphrey Rang
|
| 250 |
|
|
|a Second edition
|
| 264 |
|
0 |
|a New York :
|b Pharmaceutical press
|c c2013
|
| 300 |
|
|
|a xiv, 345 pages :
|b illustrations (some colour) ;
|c 25 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 504 |
|
|
|
| 505 |
0 |
|
|a The development of the pharmaceutical industry -- 2. The nature of disease and the purpose of therapy -- 3. Therapeutic modalities -- 4.The drug discovery process : general principles and some case histories -- 5. Choosing the project -- 6. Choosingthe target -- 7.The role of information, bioinformatics and genomics -- 8. High-throughput screening -- 10.The role of medicinal chemistry in the drug discovery process -- 11. DMPK optimization strategy in drug discovery -- 12. Pharmacology : its role in drug discovery -- 13. Biopharmaceuticals -- 14. Scaffolds: small globular proteins as antibody substitutes -- 15. Drug development : introduction
|
| 650 |
|
0 |
|a Drug Discovery
|
| 650 |
|
0 |
|a Biopharmaceutics
|
| 650 |
|
0 |
|a Technology, Pharmaceutical
|
| 700 |
1 |
|
|a Hill, Raymond ,
|e editor
|
| 700 |
1 |
|
|a Rang, Humprey ,
|e editor
|
| 999 |
|
|
|a 1000177536
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|